| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2000 ( Subtotal = $250,000 ) |
| | 2000 | 2000 | INTRAIMMUNE THERAPIES, INC | POST OFFICE BOX 1419 | CONCORD | MA | 01742 | MIDDLESEX | USA | R42NS038002 | INTRABODY CONTROL OF EXPANDED-REPEAT NEURODEGENERATION | 000 | 2 | NIH | 2/11/2000 | $250,000 |
|
| Issue Date FY: 1998 ( Subtotal = $100,000 ) |
| | 1998 | 1998 | INTRAIMMUNE THERAPIES, INC | POST OFFICE BOX 1419 | CONCORD | MA | 01742 | MIDDLESEX | USA | R41NS038002 | INTRABODY CONTROL OF EXPANDED REPEAT NEURODEGRATION | 000 | 1 | NIH | 7/27/1998 | $100,000 |
|
| Issue Date FY: 1997 ( Subtotal = $99,994 ) |
| | 1997 | | INTRAIMMUNE THERAPIES, INC | POST OFFICE BOX 1419 | CONCORD | MA | 01742 | MIDDLESEX | USA | R41HL57636 | NON VIRAL GENE DELIVERY TO HEMATOPOIETIC STEM CELLS | 000 | 01 | NIH | 9/29/1997 | $99,994 |
|
| Issue Date FY: 1996 ( Subtotal = $100,000 ) |
| | 1996 | | INTRAIMMUNE THERAPIES, INC | POST OFFICE BOX 1419 | CONCORD | MA | 01742 | MIDDLESEX | USA | R43CA72339 | DESIGNING GENETIC IMMUNOTOXINS THAT TREAT NEUROBLASTOMA | 000 | 01 | NIH | 8/7/1996 | $100,000 |
|
|
